Affinity Investment Advisors, LLC Lantheus Holdings, Inc. Transaction History

Affinity Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$55.6 - $77.89 $158,571 - $222,142	-2,852 Reduced 41.01%	4,102 $254,000
Q3 2023 Oct 26, 2023	BUY	$60.27 - $90.75 $18,683 - $28,132	310 Added 4.67%	6,954 $483,000
Q2 2023 Aug 10, 2023	BUY	$82.41 - $99.65 $547,532 - $662,074	6,644 New	6,644 $557,000
Q3 2018 Nov 09, 2018	SELL	$13.1 - $16.35 $257,284 - $321,114	-19,640 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$14.85 - $24.3 $21,532 - $35,235	1,450 Added 7.97%	19,640 $312,000
Q4 2017 Feb 07, 2018	BUY	$17.4 - $23.4 $3,323 - $4,469	191 Added 1.06%	18,190 $372,000
Q3 2017 Oct 31, 2017	BUY	$15.5 - $19.15 $278,984 - $344,680	17,999	17,999 $320,000

534

68.9M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.16B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Affinity Investment Advisors, LLC with notifications on news.